What types of thyroid cancer exist and how do they differ? 

Thyroid cancer is a condition that occurs when cells within the thyroid gland undergo genetic mutations that allow them to grow and multiply uncontrollably. While the thyroid is a single organ, the cancers that arise from it are not all the same. They differ significantly in terms of the cells they originate from, how quickly they grow, and the way they spread throughout the body. In the United Kingdom, doctors categorise these cancers into several distinct types to determine the most effective course of treatment and to provide an accurate prognosis for the patient. Most thyroid cancers are highly treatable and have an excellent outlook, but understanding the specific type is the first step in the journey toward recovery. 

What We’ll Discuss in This Article 

• The characteristics of differentiated thyroid cancers like papillary and follicular. 

• The unique origins and genetic links of medullary thyroid cancer. 

• The aggressive nature and management of anaplastic thyroid cancer. 

• Rare forms of the disease including thyroid lymphoma and sarcoma. 

• How the different types vary in their methods of spreading. 

• The impact of cancer type on the choice of surgical and medical treatments. 

Differentiated thyroid cancers are the most common forms of the disease. 

The majority of thyroid cancers in the United Kingdom fall into the category of differentiated thyroid cancer. This term means that when the cancer cells are viewed under a microscope, they still look very much like normal, healthy thyroid cells. Differentiated cancers develop from the follicular cells, which are the cells responsible for producing and storing thyroid hormones. Because these cells retain some of the features of normal thyroid tissue, they often respond well to traditional treatments like radioactive iodine therapy. According to NHS information on thyroid cancer, these types are generally slow growing and have a very high cure rate. 

The most frequent type of differentiated thyroid cancer is papillary thyroid cancer. It accounts for approximately 80 per cent of all cases and is most commonly diagnosed in people under the age of 40, particularly women. Papillary cancer tends to grow very slowly and often develops in only one lobe of the gland. While it can spread to the lymph nodes in the neck, it remains highly treatable even when this occurs. Another form is follicular thyroid cancer, which makes up about 10 to 15 per cent of cases. This type is more common in older adults and in geographical areas where there is a history of iodine deficiency. Unlike papillary cancer, follicular cancer is less likely to spread to the lymph nodes but may spread through the blood to distant organs like the lungs or bones. 

Medullary thyroid cancer arises from specialised C cells. 

Medullary thyroid cancer is a rarer and more complex form of the disease, accounting for approximately 2 to 5 per cent of all thyroid cancers in the United Kingdom. It differs fundamentally from differentiated thyroid cancers because it does not start in the follicular cells. Instead, it originates in the parafollicular cells, also known as C cells. These specialised cells do not produce thyroxine, their primary role is to produce a hormone called calcitonin, which helps to regulate calcium levels in the blood. Because medullary cancer cells do not absorb iodine, traditional radioactive iodine therapy is not an effective treatment for this specific type. 

There are two distinct ways that medullary thyroid cancer can develop. The most common form is sporadic, which occurs randomly and is not inherited. It usually develops in one lobe and affects older adults. The second form is familial medullary thyroid cancer, which is caused by an inherited faulty gene. This form is often associated with other endocrine system problems as part of a syndrome called Multiple Endocrine Neoplasia type 2. In these cases, the cancer can develop at a much younger age, sometimes even in childhood. Clinical guidance from NICE highlights that patients with medullary thyroid cancer often require genetic testing and specific blood tests to monitor calcitonin levels, which serve as a marker for the disease. 

Anaplastic thyroid cancer is a rare and aggressive form of the condition. 

Anaplastic thyroid cancer is the least common type, representing only about 1 to 2 per cent of all cases. It is also the most serious and aggressive form of the disease. Unlike differentiated cancers, anaplastic cancer cells are undifferentiated, meaning they look nothing like normal thyroid cells under a microscope. They have lost all the specialised functions of healthy tissue and grow at a very rapid pace. This type of cancer is most frequently diagnosed in older people, typically those over the age of 60, and it is slightly more common in women. 

Because of its aggressive nature, anaplastic thyroid cancer often presents as a rapidly enlarging lump in the neck that can quickly cause pressure on the windpipe or the food pipe. It is more likely than other types to have spread to other parts of the body by the time it is diagnosed. Treatment for anaplastic cancer is challenging and usually requires a combination of surgery, radiotherapy, and chemotherapy to slow its progression. While the prognosis for this type is generally not as good as for other thyroid cancers, modern medical teams in the UK work together to provide intensive support and tailored treatment plans for every patient. 

Rare types including thyroid lymphoma and sarcoma. 

Beyond the four main categories, there are several very rare types of cancer that can develop within the thyroid gland. One of these is thyroid lymphoma, which starts in the immune system cells that reside within the thyroid. This type is often linked to a history of Hashimoto’s thyroiditis, a condition where the immune system attacks the thyroid over many years. Thyroid lymphoma often presents as a fast growing neck lump and responds well to chemotherapy and radiotherapy rather than surgery. 

Another rare form is thyroid sarcoma, which develops in the connective tissues of the gland, such as the blood vessels or nerves. These are extremely infrequent and are treated similarly to sarcomas found in other parts of the body. In some cases, a cancer that started in another organ, such as the breast or kidney, can spread to the thyroid gland, although this is technically a secondary cancer rather than a primary thyroid cancer. Each of these rare forms requires a specialist approach and is managed by a multidisciplinary team within the NHS to ensure the best possible care. 

The difference in monitoring and follow up care. 

Following treatment, the way patients are monitored also depends on the type of cancer they had. For those with differentiated thyroid cancer, doctors use a blood test to measure thyroglobulin. This is a protein only made by thyroid cells. If the thyroid has been removed and treated with iodine, the thyroglobulin level should be zero or very low. A rising level can be an early sign that the cancer has returned. 

Patients with medullary thyroid cancer are monitored using two different blood markers: calcitonin and carcinoembryonic antigen (CEA). These provide a clear picture of whether any C cells remain in the body. For anaplastic cancer, follow up is much more frequent and often involves repeated imaging scans like CT or MRI to check the neck area. This tailored follow up ensures that any recurrence is caught at the earliest possible stage, allowing for further treatment to be initiated promptly. 

Cancer Type	Cell of Origin	Common Age Group	Main Spread Method	Iodine Response
Papillary	Follicular	20 to 50 years	Lymph nodes	Good
Follicular	Follicular	40 to 60 years	Bloodstream	Good
Medullary	C cells	Any (often >50)	Lymph and Blood	None
Anaplastic	Follicular (undifferentiated)	Over 60 years	Local invasion	None
Lymphoma	Immune cells	Over 60 years	Local and Lymph	None

Conclusion 

There are several types of thyroid cancer, with differentiated forms like papillary and follicular being the most common and highly treatable. Medullary thyroid cancer is rarer and originates from different cells, while anaplastic thyroid cancer is a more aggressive form requiring rapid intervention. Each type differs in its biological behaviour, method of spread, and response to treatments such as radioactive iodine. While a diagnosis is naturally concerning, the majority of thyroid cancers identified in the United Kingdom have an excellent prognosis with modern medical care. If you experience severe, sudden, or worsening symptoms, such as significant difficulty breathing or a rapidly enlarging neck lump, call 999 immediately. 

Authority Snapshot 

This article provides a medically accurate overview of the various types of thyroid cancer according to current UK clinical standards. The content has been authored by Dr. Rebecca Fernandez, a UK trained physician with extensive experience in internal medicine, surgery, and cardiology. The information provided is strictly aligned with the evidence based guidance from the NHS and NICE to ensure the highest level of patient safety and educational reliability.